| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $13,737 | $14,396 | $15,438 | N/A | $16,662 |
| Gross Profit | $2,014 | $2,084 | $2,244 | N/A | $2,798 |
| Operating Income | $1,152 | $1,088 | $621 | N/A | $1,827 |
| Net Income | $753 | $685 | $199 | N/A | $1,254 |

Edwyn
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $13,737 | $14,396 | $15,438 | N/A | $16,662 |
| Gross Profit | $2,014 | $2,084 | $2,244 | N/A | $2,798 |
| Operating Income | $1,152 | $1,088 | $621 | N/A | $1,827 |
| Net Income | $753 | $685 | $199 | N/A | $1,254 |
Over the period from 2021 to 2025, Leidos Holdings, Inc. demonstrated an overall upward trend in revenue and gross profit, suggesting a resilient revenue-generating capability within its industry. Revenue increased from US$13,737 million in 2021 to US$16,662 million in 2025—a growth of approximately 21% over the period. Gross profit similarly rose from US$2,014 million in 2021 to US$2,798 million in 2025, representing roughly a 39% increase. These positive movements suggest that the company has maintained its pricing power or managed cost of goods sold effectively, despite fluctuations in other operational metrics. Operating income and net income, however, present a more volatile picture. After recording operating income of US$1,152 million in 2021 and US$1,088 million in 2022, the company experienced a significant downturn in 2023, with operating income falling to US$621 million—a decline of nearly 43% from 2021. Net income also dropped sharply from US$753 million in 2021 to US$199 million in 2023. Notably, 2025 saw a robust recovery with operating income surging to US$1,827 million and net income climbing to US$1,254 million, signaling a substantial turnaround (over 190% improvement in operating income and a more than 500% rebound in net income from 2023 levels). The zero values reported for 2024, likely a reporting gap, emphasize the importance of completing full-year data for a comprehensive trend analysis. Overall, based on the available metrics, Leidos appears to be financially healthy and capable of rebounding from operational setbacks, with improved efficiency and profitability in its more recent performance.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.